Medtronic has launched its pure titanium coating (PTC) platform of interbody fusion devices designed to ease pain from spinal surgeries.
The PTC platform is comprised of four products including: the Capstone PTC spinal system, Clydesdale PTC spinal system, Anatomic Peek PTC cervical fusion system and the Cornerstone-SR ti-coated anatomical cervical cage.
These devices have been developed for the treatment of patients experiencing pain caused by compression of the spinal cord or nerve roots, and helps to restore normal disc height.
The company said that disc height restoration may reduce the pressure on the nerve roots and the spinal cord, as well as help alleviate the patient's pain.
The PTC devices are made of a combination of titanium and polyetheretherketone (PEEK), materials most commonly used in interbody fusion procedures.
Medtronic senior vice-president Doug King said: "Our PTC platform of interbody spacers is the result of our relentless effort to add value to our products and respond to surgeon needs by offering the advantages of combined materials in a single implant.
"We will continue to leverage our innovation to produce more advanced and differentiated products for surgeons to use to treat their patients."
In March, US Food and Drug Administration (FDA) granted 510(k) approval for the Capstone PTC spinal system and Clydesdale PTC spinal system. They were introduced in the US in August.
These devices are developed for interbody fusion with autogenous bone graft in patients with degenerative disc disease (DDD) at one or two levels from L2 to S1, and for interbody fusions in the lower back or lumbar spine.
The company intends to launch the Capstone PTC spinal system in Japan in November 2015 and the Clydesdale PTC spinal system in January 2016.
The FDA 510(k) approved Anatomic Peek PTC cervical fusion system was introduced in the US in September. It is indicated for degenerative discopathy and instability, as well as pseudarthrosis or failed arthrodesis.
The CE Mark approved Cornerstone-SR ti-coated anatomical cervical cage is currently available in Western Europe, and is indicated for cervical interbody fusion procedures in skeletally mature patients with cervical disc disease at one level from the C2-C3 disc to the C7-T1 disc.